These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18843537)

  • 21. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D; Vrečer F
    Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet.
    Park C; Lee JH; Jin G; Ngo HV; Park JB; Tran TTD; Tran PHL; Lee BJ
    Curr Drug Deliv; 2022; 19(5):520-533. PubMed ID: 34420504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose.
    Sahoo J; Murthy PN; Biswal S; Sahoo SK; Mahapatra AK
    AAPS PharmSciTech; 2008; 9(2):577-82. PubMed ID: 18459050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
    Košir D; Ojsteršek T; Vrečer F
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers.
    Roy H; Brahma CK; Nandi S; Parida KR
    Int J Appl Basic Med Res; 2013 Jan; 3(1):55-63. PubMed ID: 23776841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
    Loh ZC; Elkordy AA
    Curr Drug Deliv; 2015; 12(4):425-43. PubMed ID: 25924732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
    Roberts M; Vellucci D; Mostafa S; Miolane C; Marchaud D
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1068-76. PubMed ID: 22149472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB; Lim J; Kang CY; Lee BJ
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
    Varshosaz J; Tavakoli N; Kheirolahi F
    AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV; Chotai NP; Patel MP
    Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of the in vitro release of carbamazepine from tablets.
    Uzunović A; Vranić E; Hadzidedić S
    Bosn J Basic Med Sci; 2010 Aug; 10(3):234-8. PubMed ID: 20846131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
    Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation Development and Optimization of Matrix Tablet of Tramadol Hydrochloride.
    Deb P; Singha J; Chanda I; Chakraborty P
    Recent Pat Drug Deliv Formul; 2017; 11(1):19-27. PubMed ID: 27712568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine.
    Ikinci G; Capan Y; Senel S; Alaaddinoğlu E; Dalkara T; Hincal AA
    Pharmazie; 2000 Oct; 55(10):762-5. PubMed ID: 11082839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of coformers on phase transformation and release profiles of carbamazepine cocrystals in hydroxypropyl methylcellulose based matrix tablets.
    Qiu S; Li M
    Int J Pharm; 2015 Feb; 479(1):118-28. PubMed ID: 25542989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers.
    Lake OA; Olling M; Barends DM
    Eur J Pharm Biopharm; 1999 Jul; 48(1):13-9. PubMed ID: 10477323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
    Tayel SA; Soliman II; Louis D
    Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Prosopis africana Seed Gum as an Extended Release Polymer for Tablet Formulation.
    Nadaf S; Nnamani P; Jadhav N
    AAPS PharmSciTech; 2015 Jun; 16(3):716-29. PubMed ID: 25523143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.